| PUBCHEM ID |
73425481
|
| UNII |
7PXE1CI5JQ
|
| Preferred Term |
.ALPHA.-HEXABROMOCYCLODODECANE, (+)-
|
| CAS |
138257-19-9
|
| INCHIKEY |
DEIGXXQKDWULML-URIQBSJHSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
Br[C@H](CC[C@@H]([C@H](CC[C@H]([C@H](CC1)Br)Br)Br)Br)[C@H]1Br
|
| Total Surface Area |
269,34
|
| Relative PSA |
0
|
| TPSA |
0
|
| cLogS |
-6,584
|
| MW |
641,699
|
| cLogP |
7,3266
|
| H-Acceptors |
0
|
| H-Donors |
0
|
| Ro5 violations |
2
|
| Druglikeness |
-12,162
|
| DrugScore |
2,82450211433121E-02
|
| Mutagenic |
high
|
| Tumorigenic |
low
|
| Reproductive Effective |
low
|
| Irritant |
low
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2+
|
| Caco-2 Permeability II |
1,5993
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Lysosome
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,9452
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5383
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
IV
|
| Rat Acute Toxicity |
1,839
|
| Carcinogenicity (Three-class) |
Non-required
|
